


| Key | % Net Assets |
|---|---|
| 7.1% | |
| 6.7% | |
| 6.7% | |
| 5.5% | |
| 74% |
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline | 7.1% |
| AstraZeneca | 6.7% |
| GlaxoSmithKline | 6.7% |
| Reynolds American | 5.5% |
| Vodafone | 5.0% |
| Reynolds American | 4.9% |
| Tesco | 4.6% |
| BP | 4.3% |
| National Grid | 4.3% |
| Imperial Tobacco | 4.0% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 209.12p |
| Currency | GBP |
| Change | 0.33p |
| % | 0.16% |
| YTD change | 23.98p |
| YTD % | 12.95% |
| Fund Inception | 16/06/1979 |
|---|---|
| Fund Manager | Neil Woodford |
| TER | 1.19 (31-Dec-2013) |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | n/a |
| Savings | £20 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.16% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research